Graft vs. host disease (GVHD) can occur after a stem cell transplant from a donor. Transplants replace unhealthy cells with healthy blood-forming cells, which can treat some cancers. GVHD happens when ...

Equillium, Inc. (NASDAQ:EQ) released topline data on Thursday from the Phase 3 EQUATOR study. The study evaluated itolizumab in the first-line treatment of patients with acute graft-versus-host ...

SEATTLE — March 5, 2025 — Below are summaries of recent Fred Hutch Cancer Center research findings, patient stories and other news. March is the awareness month for colorectal cancer and multiple ...

Fred Hutch bone marrow transplant and GVHD expert Dr. Geoffrey Hill explains how a new approach has changed the BMT landscape, where research is headed next Now, more than 1.5 million transplants have ...

Overall survival in hematopoietic stem cell transplant patients with hematologic malignancies: Accounting for the unobserved risk factors. This is an ASCO Meeting Abstract from the 2025 ASCO Annual ...

MiNK Therapeutics receives an NIAID grant to develop iNKT cell therapies for preventing graft-versus-host disease in stem cell transplants. MiNK Therapeutics, Inc., a biopharmaceutical company ...

Certain foods can be unsafe or cause GI pain when you’re managing graft-versus-host disease (GVHD). To prevent uncomfortable symptoms or healing issues, dietitians recommend avoiding these foods.

A research team has identified the impact of stem cell infusion timing on the incidence and severity of acute graft-versus-host disease (aGVHD) in allogeneic hematopoietic stem cell transplantation ...

Caspian Oliai, MD, MS, medical director of the UCLA Bone Marrow Transplantation Stem Cell Processing Center, discusses findings from the phase 3 Precision-T trial of Orca-T in acute leukemia and ...

Patients who underwent hematopoietic cell transplantation for sickle cell disease saw high rates of survival without disease symptoms and low rates of severe side effects or complications years after ...